Oxyntomodulin is a gut peptide released in response to a meal. It is synthesized within specialized enteroendocrine cells called L cells. Oxyntomodulin is released from the intestinal L cells 5-10 minutes after ingestion of food in amounts proportional to calorie intake and levels peak 30 minutes after meals. Oxyntomodulins are …
Read More »Diabetes In Control
Editor’s Note: Anti-inflammatory Steroids and “Hypoglycemia”
There has been a shortage of methylprednisolone and prednisone dose packs available in pharmacies lately and this week’s Disaster Averted deals with what happens when patients get their anti-inflammatory steroids in a bottle instead of a pack. If you’re thinking that the problem is hyperglycemia then you need to review …
Read More »Letter from the Editor #582
The National Committee for Quality Assurance (NCQA) recently held a series of webinars to help clinicians in “Achieving and Outperforming Type 2 Diabetes HEDIS Measures.“ There were a lot of elements that needed to fall into place to make that happen and our Pharm D candidate, Daniel Schultz, listened in …
Read More »Managing Clinical Problems in Diabetes, Case Study #13: Gestational Diabetes
Edited by Trisha Dunning AM, RN, MEd, PhD, CDE, FRCNA and Glenn Ward MBBS, BSc, DPhil (Oxon), FRACP, FRCPath Mrs. ORA was referred to a diabetes educator when she developed diabetes at 29.5 weeks’ gestation. Mrs. ORA is a 30-year-old primigravida and is 29.5 weeks pregnant. She was referred to the …
Read More »Diagnosis and Management of Diabetic Eye Disease, Part 6 of 7
This week’s slides on Diabetic Eye Disease cover the Staging of Diabetic Macular Edema, Referral & Follow-up for DR, Treatment of DR-PRP, Treatment of DR – Vitrectomy, and Treatment of CSME….
Read More »Achieving and Outperforming Type 2 Diabetes HEDIS Measures
A Guide for Managed Care to Provide Clinicians with Tools to Support the Delivery of Consistent High-Quality Care Reviewed by Daniel Schultz, Doctor of Pharmacy Candidate, University of Florida College of Pharmacy The first presentation focused on HEDIS, a widely used set of measurements of healthcare performance …
Read More »Diabetes and Fasting
People fast for many reasons: blood tests, surgery or other kind of procedure, or for religious reasons. The Diabetes and Fasting handout will guide your patients who need to fast with some tips for those on oral meds or insulin. Download Diabetes and Fasting (pdf) here For …
Read More »iGlucose
iGlucose iglucose uses mobile technology to change the way individuals with diabetes manage their condition. By seamlessly communicating data from glucometers to the iglucose diabetes management portal, glucose readings can be shared in real-time with family members, caregivers and health care professionals. iglucose eliminates the burden of keeping logbooks and …
Read More »Bydureon: Made in the U.S.A for Europeans
Amylin Pharmaceuticals received its first regulatory approval in Europe while approval of the diabetes drug has been delayed at least a year in the US. The approval by the European Commission in June means the 300 employees Amylin has at its manufacturing facility in Ohio will switch gears from making …
Read More »Obesity Epidemic in US Continues to Spread
Today, the state with the lowest obesity rate would have had the highest rate in 1995. Despite new initiatives aimed at various sectors of society, including schools and restaurants, obesity rates did not drop in one single US state last year, and rose in 16 of them. Twelve states have …
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.